Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.
Lawyers will meet today with the federal judge presiding over all hair relaxer lawsuits, as women diagnosed with uterine, endometrial and ovarian cancer continue to file claims throughout the U.S. court system.
